The proposed sale is small and consistent with the insider's prior pattern of selling vested equity awards. No unusual insider behavior is signaled. Monitor future Form 4 filings to confirm execution, but this filing alone does not warrant a change in outlook.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 3 $140.30entry
- T+1 · 13d ago +1.63%α −0.03% · $142.58
- T+5 · 7d ago −5.82%α −5.24% · $132.13
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Paula Green, an officer of Twist Bioscience, filed a Form 144 notice of intent to sell 1,007 shares of common stock, valued at approximately $136,350. The shares were acquired through restricted stock vesting on November 2, 2026. This is a small, routine sale relative to the company's $11.5B market cap and the insider's prior trading pattern, and it carries no material signal.
Key Facts
- Paula Green, an officer of Twist Bioscience, filed a Form 144 on November 3, 2026.
- The notice covers the proposed sale of 1,007 shares of common stock.
- The approximate market value of the proposed sale is $136,349.51.
- The shares were acquired on November 2, 2026, through restricted stock vesting.
- The filing indicates the sale is intended to occur on or after November 3, 2026, on Nasdaq.
- The insider has a history of routine sales: four prior sales from August to October 2026 totaling 13,842 shares (including a 10,088-share sale on Oct 2 for tax withholding).
Financial Impact
Proposed sale of 1,007 shares valued at ~$136,350, representing less than 0.001% of Twist's $11.5B market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed.
- The insider has a history of routine sales, so this filing is not indicative of a change in sentiment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007691 |
| Document: 0001959173-26-007691-index.html | 0001959173-26-007691 |
| Document: 0001959173-26-007691.txt | 0001959173-26-007691 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers